advertisement
Abstract #9267 Published in IGR 5-2
Optimal photocoagulation for neovascular glaucoma secondary to diabetic retinopathy
Kiuchi K; Yamada H; Kawai E; Fujiseki Y; Wada M; Moriguchi K; Tsumura A; Hatano H; Matsumura MJapanese Journal of Clinical Ophthalmology 2003; 57: 1099-1103
PURPOSE: To identify the number of laser spots necessary for prevention of neovascular glaucoma in diabetic retinopathy. CASES: The authors reviewed 40 eyes of 29 diabetic patients who had received photocoagulation for iris or angle neovascularization during the past six years. They were followed up for six months or longer. The series comprised 32 eyes of 22 males and eight eyes of seven females. Their ages ranged from 33-74 years; average, 58 years. RESULTS: The number of photocoagulation ranged from 613 to 4655 spots per eye, with 1725 spots as the median. The visual outcome was significantly better in eyes receiving more than 1725 spots (p < 0.05). CONCLUSION: In treating or preventing neovascular glaucoma in diabetic retinopathy, more than 1725 laser spots should be applied to obtain a better visual outcome. LA: Japanese
Dr. K. Kiuchi, Department Ophthalmology, Kansai Medical University, 6-9-19 Higashi Nakahama Joto Ku, Osaka-shi, 536-0023, Japan
Classification:
9.4.5.1 Neovascular glaucoma (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders > 9.4.5 Glaucomas associated with disorders of the retina, choroid and vitreous)
12.20 Other (Part of: 12 Surgical treatment)
